Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D

By S. Walters, J. Brazier. Quality of Life Research, 2005

1,337 citations recorded by the source corpus.

Subfields: Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/68ccf777d01c0610651ac6e6ca3a2eacf350a35c

Citations in the corpus

• Emicizumab Prophylaxis in Hemophilia A with Inhibitors (2017, neutral): “(%) Mild 2 (6) 0 1 (2) 0 3 (3) Moderate 2 (6) 0 1 (2) 1 (14) 4 (4) Severe 31 (89) 18 (100) 47 (96) 6 (86) 102 (94) ≥9 Bleeding events in 24 wk before trial entry — no.”